Sort
64,565 grants matching “drug discovery”
Delineating the role of let-7 microRNA on lung AT2 cell homeostasis, alveolar regeneration, and interstitial lung disease
$515,003Antony Rodriguez · Baylor College Of Medicine · R01 · FY2024 · HL
Examining the determinants and consequences of supportive care medication use disparities in patients with pancreatic cancer: A sequential mixed-methods approach
$514,964John M Allen · University Of Florida · R01 · FY2024 · MD
Project 4: Post-Exposure Biomarkers and Remediation of Radionuclide Contaminants
$514,890Rebecca J Abergel · Northwestern University At Chicago · P01 · FY2023 · AI
On-Chip Assay for Identifying Candidate Microtubule Binding Drugs to Treat ADRDs
$514,862Stanislav Karsten · Neuroindx Inc. · R43 · FY2024 · AG
K-Ras sumoylation in cell proliferation and transformation
$514,857Wei Dai · New York University School Of Medicine · R01 · FY2017 · CA
Coordinate Regulation of Bacterial Virulence Factors
$514,790John J Mekalanos · Harvard Medical School · R01 · FY2012 · AI
A Novel Drug for Septicemia Targets A1 ARs
$514,777Constance Neely Wilson · Endacea, Inc. · R42 · FY2010 · AI
Epac1 as a novel therapeutic target for diabetic retinopathy
$514,763Xiaodong Cheng · University Of Texas Hlth Sci Ctr Houston · R01 · FY2022 · EY
Preclinical microphysiological tumor models for nuclear medicine
$514,734Guillem Pratx · Stanford University · R01 · FY2025 · CA
BindingDB: A Tool for Drug Discovery, Modeling and Chemical and Systems Biology
$514,707Michael K. Gilson · University Of California, San Diego · R01 · FY2015 · GM
RNA Helicase Mutations in Myelodysplastic Syndrome: New Therapeutic Target
$514,645Jaroslaw P Maciejewski · Cleveland Clinic Lerner Com-Cwru · R01 · FY2016 · HL
RNA Helicase Mutations in Myelodysplastic Syndrome: New Therapeutic Target
$514,645Jaroslaw P Maciejewski · Cleveland Clinic Lerner Com-Cwru · R01 · FY2018 · HL
RNA Helicase Mutations in Myelodysplastic Syndrome: New Therapeutic Target
$514,645Jaroslaw P Maciejewski · Cleveland Clinic Lerner Com-Cwru · R01 · FY2015 · HL
RNA Helicase Mutations in Myelodysplastic Syndrome: New Therapeutic Target
$514,645Jaroslaw P Maciejewski · Cleveland Clinic Lerner Com-Cwru · R01 · FY2017 · HL
Toward urinary catheterization with long-term resistance to bacterial colonization
$514,604Olga Zolotarskaya · Wynnvision, Llc · R44 · FY2023 · DK
Cell autonomous and non-autonomous mechanisms in Alzheimer's disease and related dementias
$514,600Lisa M. Ellerby · Buck Institute For Research On Aging · P01 · FY2024 · AG
Microchip devices to assay quantal exocytosis
$514,595Kevin D Gillis · University Of Missouri-Columbia · R01 · FY2008 · NS
Small Molecule Drug Discovery for CLN3 and CLN6 Disease
$514,561Paul Trippier · University Of Nebraska Medical Center · R01 · FY2023 · HD
Tools for rapid and accurate structure elucidation of natural products
$514,429William H Gerwick · University Of California, San Diego · R01 · FY2020 · GM
Academic-Industrial Partnership for Translation of Acoustic Angiography
$514,371Paul A Dayton · Univ Of North Carolina Chapel Hill · R01 · FY2016 · CA
Identification of Small Molecules that Influence Trafficking of the GnRH Receptor
$514,347P. Michael Conn · Texas Tech University Health Scis Center · R01 · FY2016 · DK
Immunology Team Contributions to the LSB
$514,339Ronald Germain · National Institute Of Allergy And Infectious Diseases · ZIA · FY2016 · AI
Suppressing the latent reservoir with a Tat inhibitor
$514,330Susana T Valente · Scripps Florida · R33 · FY2017 · AI
High Throughput Intracellular Drug Screening Platform
$514,269Cristian Ionescu-Zanetti · Fluxion Biosciences, Inc. · R44 · FY2008 · GM
Target discovery and combination therapy in KRAS mutant cancer
$514,251Ji Luo · Division Of Basic Sciences - Nci · ZIA · FY2025 · CA